Pages that link to "Q52708653"
Jump to navigation
Jump to search
The following pages link to Analysis of the performance of pathologists in the grading of bladder tumors. (Q52708653):
Displaying 50 items.
- Superficial bladder cancer. (Q33209244) (← links)
- Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer (Q33808362) (← links)
- Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma (Q33838528) (← links)
- Quality assessment in cervical cytology: a pilot study (Q33838848) (← links)
- Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung (Q34173005) (← links)
- Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer (Q34390864) (← links)
- The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement? (Q35192387) (← links)
- Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression (Q35811170) (← links)
- Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer (Q35994270) (← links)
- Quantitative Light Microscopy in Urological Oncology (Q36247210) (← links)
- The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence (Q36249221) (← links)
- Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement (Q36358049) (← links)
- Reproducibility and reliability of tumor grading in urological neoplasms (Q36935404) (← links)
- Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target (Q36958930) (← links)
- Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors (Q37074139) (← links)
- Histopathology reporting of mastectomy specimens--an assessment of inter-hospital variation (Q37176447) (← links)
- Transitional carcinoma of the upper urinary tract: a histological and cytopathological study (Q37203336) (← links)
- Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders (Q37254722) (← links)
- Ploidy of smooth muscle tumours: retrospective image analysis study of formalin fixed, paraffin wax embedded tissue (Q39645199) (← links)
- Clinical applications of DNA flow cytometry for bladder tumors (Q40171570) (← links)
- Subspecialty surgical pathologist's performances as triage pathologists on a telepathology-enabled quality assurance surgical pathology service: A human factors study (Q40209916) (← links)
- Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma (Q40484960) (← links)
- Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors (Q40762408) (← links)
- Superficial bladder carcinoma. Factors affecting the natural history (Q40860518) (← links)
- Prognostic factors in superficial bladder cancer (Q40860524) (← links)
- Follow-up of patients with "superficial" transitional cell carcinoma of the bladder: the case for a change in policy (Q40860891) (← links)
- Factors influencing the subjective grading of bladder cancer (Q41385577) (← links)
- Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder (Q42382564) (← links)
- Utility of serial urinary tumor markers to individualize intervals between cystoscopies in the monitoring of patients with bladder carcinoma (Q42514714) (← links)
- Molecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosis (Q42936872) (← links)
- Prognostic significance of dna content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas (Q43698437) (← links)
- Comparison of quantitative and classic prognosticators in urinary bladder carcinoma. A multivariate analysis of DNA flow cytometric, nuclear morphometric and clinicopathological features (Q43813386) (← links)
- Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma (Q43831201) (← links)
- Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade (Q43924805) (← links)
- Long-term survival of patients with bladder tumours: the significance of risk factors (Q44017782) (← links)
- Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer (Q44893697) (← links)
- Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index (Q44963195) (← links)
- BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer. (Q45063336) (← links)
- Prediction of T1-2 GI-II transitional cell bladder cancer; evaluation by histoquantitative methods (Q45088390) (← links)
- Prognostic value of angiogenesis in schistosoma-associated squamous cell carcinoma of the urinary bladder. (Q46456221) (← links)
- Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma (Q47379090) (← links)
- Comparison of DNA Ploidy and Nuclear Morphometric Parameters with the Conventional Prognostic Factors in Transitional Cell Carcinomas (Q47964499) (← links)
- Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. (Q52865237) (← links)
- The reliability of staging and grading of bladder tumours. Impact of misinformation on the pathologist's diagnosis. (Q52884636) (← links)
- Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study. (Q53029801) (← links)
- Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility. (Q53083086) (← links)
- Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice. (Q53130577) (← links)
- Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder. (Q53297019) (← links)
- Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. (Q53312517) (← links)
- World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors: reply. (Q53337638) (← links)